###begin article-title 0
ApoB100-LDL Acts as a Metabolic Signal from Liver to Peripheral Fat Causing Inhibition of Lipolysis in Adipocytes
###end article-title 0
###begin p 1
Conceived and designed the experiments: JS AD MR SV DL PA EW PA JB. Performed the experiments: JS AD MR G HB AM DL PA EW PA JB. Analyzed the data: JS AD MR G RN HB SV AM DL PA EW JT PA JB. Contributed reagents/materials/analysis tools: DL PA EW JT AH PA JB. Wrote the paper: JS AD MR HB SV DL AH PA JB.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Free fatty acids released from adipose tissue affect the synthesis of apolipoprotein B-containing lipoproteins and glucose metabolism in the liver. Whether there also exists a reciprocal metabolic arm affecting energy metabolism in white adipose tissue is unknown.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 1022 1025 1022 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1018 1029 1018 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup>Apob</italic>
###xml 1029 1036 1029 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 168 171 <span type="species:ncbi:9606">men</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 426 431 <span type="species:ncbi:9606">human</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">Mice</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
We investigated the effects of apoB-containing lipoproteins on catecholamine-induced lipolysis in adipocytes from subcutaneous fat cells of obese but otherwise healthy men, fat pads from mice with plasma lipoproteins containing high or intermediate levels of apoB100 or no apoB100, primary cultured adipocytes, and 3T3-L1 cells. In subcutaneous fat cells, the rate of lipolysis was inversely related to plasma apoB levels. In human primary adipocytes, LDL inhibited lipolysis in a concentration-dependent fashion. In contrast, VLDL had no effect. Lipolysis was increased in fat pads from mice lacking plasma apoB100, reduced in apoB100-only mice, and intermediate in wild-type mice. Mice lacking apoB100 also had higher oxygen consumption and lipid oxidation. In 3T3-L1 cells, apoB100-containing lipoproteins inhibited lipolysis in a dose-dependent fashion, but lipoproteins containing apoB48 had no effect. ApoB100-LDL mediated inhibition of lipolysis was abolished in fat pads of mice deficient in the LDL receptor (Ldlr-/-Apob100/100).
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
Our results show that the binding of apoB100-LDL to adipocytes via the LDL receptor inhibits intracellular noradrenaline-induced lipolysis in adipocytes. Thus, apoB100-LDL is a novel signaling molecule from the liver to peripheral fat deposits that may be an important link between atherogenic dyslipidemias and facets of the metabolic syndrome.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 501 504 501 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Olofsson1">[1]</xref>
Lipoproteins containing apolipoprotein (apo) B are synthesized in the liver (apoB100-very low density lipoproteins (VLDL)) or the intestine (apoB48-chylomicrons). These particles are released into the circulation, where they undergo hydrolysis by lipoprotein lipase, generating free fatty acids that are taken up by peripheral organs such as the adipose tissue. The hydrolysis also generates atherogenic remnants such as, apoB100-low density lipoprotein (LDL), a major risk factor for atherosclerosis [1].
###end p 9
###begin p 10
###xml 121 124 121 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Frayn1">[2]</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Frayn1">[2]</xref>
The intracellular lipolysis of adipocytes is believed to play a central role in regulating whole-body energy homeostasis [2], affecting both the release of free fatty acids to the circulation and the extent of peripheral fat deposits. These effects provide a metabolic link between peripheral fat deposits and the liver that influence the hepatic synthesis and secretion of lipoproteins [2]. However, the existence and possible nature of a reciprocal signal from the liver to the adipocytes have not been established.
###end p 10
###begin p 11
###xml 343 346 343 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir1">[3]</xref>
###xml 348 351 348 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir2">[4]</xref>
The size and binding properties of apoB-containing lipoproteins imply that they may have physiological functions other than the passive transport of lipids to adipocytes. Indeed, individuals with conditions characterized by high levels of apoB-containing lipoproteins have reduced levels of catecholamine-induced lipolysis in their adipocytes [3], [4].
###end p 11
###begin p 12
###xml 251 254 <span type="species:ncbi:9606">men</span>
###xml 389 394 <span type="species:ncbi:10090">mouse</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
###xml 586 591 <span type="species:ncbi:9606">human</span>
###xml 596 601 <span type="species:ncbi:10090">mouse</span>
We hypothesized that apoB-containing lipoproteins affect adipocyte lipolysis, serving as a signal from the liver to peripheral fat deposits. To test this hypothesis, we investigated lipolysis in subcutaneous fat cells from obese but otherwise healthy men in relation to their levels of apoB-containing lipoproteins. We then examined noradrenaline-induced lipolysis in genetically modified mouse models with plasma containing high or intermediate levels or no apoB100 or apoB48, and human primary cultured adipocytes and 3T3-L1 cells incubated with different types and concentrations of human and mouse apoB-containing lipoproteins. Taken together, our findings show that apoB100-LDL act as a metabolic signal causing inhibition of lipolysis in adipocytes.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 36 41 <span type="species:ncbi:9606">human</span>
Lipolysis in healthy volunteers and human primary adipocytes
###end title 14
###begin p 15
###xml 41 44 41 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir1">[3]</xref>
###xml 46 49 46 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir2">[4]</xref>
###xml 227 234 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1A</xref>
###xml 154 157 <span type="species:ncbi:9606">men</span>
In accordance with previous observations [3], [4], the rate of noradrenaline-induced lipolysis in subcutaneous fat cells from obese but otherwise healthy men correlated strongly and inversely with apoB plasma levels (r = -0.5, Fig. 1A) but was not related to apoA1 or body mass index (both r = 0.1; not shown), suggesting that apoB100-containing lipoproteins suppresses adipocyte lipolysis. The inverse correlation was also found to be independent of age and markers of the metabolic syndrome. This was investigated by multiple regression analysis using the following markers for metabolic syndrome and noradrenaline-induced lipolysis together as regressors versus apoB100 as a dependent factor, age; r = -0.27, p = 0.018; waist: r = -0.35, p = 0.005; fasting plasma insulin: r = -0.36, p = 0.002; fasting plasma HDL cholesterol: r = -0.36, p = 0.002; fasting plasma triglycerides: r = -0.32; p = 0.003; systolic blood pressure: r = -0.26, p = 0.023; diastolic blood pressure: r = -0.24, p = 0.032.
###end p 15
###begin title 16
###xml 50 55 <span type="species:ncbi:9606">human</span>
Effects of apoB100, VLDL, and LDL on lipolysis in human fat cells.
###end title 16
###begin p 17
###xml 123 126 <span type="species:ncbi:9606">men</span>
###xml 341 346 <span type="species:ncbi:9606">human</span>
###xml 446 451 <span type="species:ncbi:9606">human</span>
###xml 531 536 <span type="species:ncbi:9606">human</span>
###xml 593 598 <span type="species:ncbi:9606">human</span>
###xml 1043 1048 <span type="species:ncbi:9606">human</span>
###xml 1486 1491 <span type="species:ncbi:9606">human</span>
###xml 1537 1542 <span type="species:ncbi:9606">human</span>
(A) Linear regression plot of fat cell lipolysis (glycerol release) and plasma apoB100 levels in 48 overweight but healthy men. The linear regression r-value = -0.5, p<0.001. (B) Basal (n = 9; p = 0.94; DF = 2,24; F-value = 0.065) and (C) noradrenaline-stimulated (noradrenaline/basal) (n = 9; p<0.05; DF = 2,24; F-value = 3.6) lipolysis in human differentiated pre-adipocytes incubated with equal concentrations (40 microg apoB100/ml medium) of human VLDL or LDL or with vehicle alone for 48 hours. (D) Inhibition of lipolysis in human differentiated pre-adipocytes incubated without or with human LDL at five concentrations (20, 30, 40, 60, 80 microg apoB100/ml medium) for 48 hours (n = 3 for each concentration; p = 0.001; DF = 2,5,10; F-value = 10.4) and (E) with different incubation times (8, 24 and 48 hours) with 40 microg apoB100/ml medium (n = 5 for each time point; DF = 2,12) p = 0.61; F-value = 0.48 for vehicle and p = 0.007; F-value = 7.6 for apoB100 incubation. (F) Noradrenaline-stimulated (noradrenaline/basal) lipolysis in human differentiated pre-adipocytes incubated with vehicle alone, native LDL and two forms of reconstituted LDL (40 microg apoB100/ml medium) for 48 hours (n = 29-34 in each group). "Trilinoleate" indicates reconstituted LDL in which cholesterol esters had been replaced with Trilinoleate. "Chol. linoleate" indicates reconstituted LDL in which cholesterol esters had been replaced with cholesteryl linoleate. (G) mRNA expression (n = 4-8) in human differentiated pre-adipocytes incubated with human LDL (40 microg apoB100/ml medium) presented as % of control cells (not exposed to LDL). Error bars in (B,C,G) indicate SD and in (D,E,F) indicate SE. p-values for (B, C, D, E) were determined by ANOVA and for (F,G) un paired t-test. *p<0.05, **p<0.01, ***p<0.001 indicate Fisher's Post-hoc test.
###end p 17
###begin p 18
###xml 250 257 250 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1B</xref>
###xml 349 356 349 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1C</xref>
###xml 397 404 397 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1D</xref>
###xml 437 444 437 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1E</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 135 140 <span type="species:ncbi:9606">human</span>
To determine the cause-effect relationship, we differentiated human preadipocytes into adipocytes and exposed them to equal numbers of human VLDL or LDL particles (i.e., equal concentrations of apoB100). Spontaneous (basal) lipolysis was unaffected (Fig. 1B); however, noradrenaline-induced lipolysis was markedly inhibited by LDL, but not by VLDL (Fig. 1C), in a concentration-dependent fashion (Fig. 1D) after incubation for 48 hours (Fig. 1E).
###end p 18
###begin p 19
###xml 205 212 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1F</xref>
Reconstitution of the cholesterol esters content of the native LDL particles with triglycerides or cholesterol ester (experimental control) did not alter the inhibition of noradrenaline-induced lipolysis (Fig. 1F).
###end p 19
###begin p 20
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir1">[3]</xref>
###xml 200 203 200 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir2">[4]</xref>
###xml 545 548 531 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Raben1">[5]</xref>
###xml 760 767 742 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1G</xref>
###xml 224 229 <span type="species:ncbi:9606">human</span>
In our previous studies of lipolysis in hyper-apoB100 conditions, noradrenaline-induced lipolysis was attenuated at the level of the protein kinase A (PKA)-hormone sensitive lipase (HSL) complex [3], [4]. RT-PCR analyses of human adipocytes incubated with LDL revealed that the mRNA levels of the regulatory 1alpha subunit of the PKA were decreased (Reg1alpha; p<0.01), whereas that of the regulatory 2beta subunit were increased (Reg 2beta; p<0.05). LDL incubation did not influence the mRNA levels of HSL or adipose triglyceride lipase (ATGL) [5]. In the fatty acid oxidation pathway, the mRNA levels of carnitine palmitoyltransferase 1 (CPT1) and peroxisome proliferator activated receptor alpha (PPARalpha) were increased, p<0.05 and p<0.01, respectively (Fig. 1G).
###end p 20
###begin title 21
###xml 52 57 <span type="species:ncbi:10090">Mouse</span>
Lipolysis in Fat Pads in Relation to Plasma apoB in Mouse
###end title 21
###begin p 22
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 204 215 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 217 220 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Raabe1">[6]</xref>
###xml 372 375 364 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Farese1">[7]</xref>
###xml 377 384 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2A</xref>
###xml 443 450 435 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2B</xref>
###xml 466 473 458 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003771-t001">Table 1</xref>
###xml 496 503 488 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2C</xref>
###xml 718 725 710 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2C</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
To assess the role of different types of apoB-containing lipoproteins in vivo, we investigated fat pad lipolysis in mice that conditionally lack microsomal triglyceride transfer protein in the liver (MttpDelta/Delta) [6] (and therefore have no apoB100-containing lipoproteins in plasma), in wild-type mice with both apoB100 and apoB48, and in mice expressing only apoB100 [7] (Fig. 2A). These groups exhibited no differences in fat cell size (Fig. 2B), body weight (Table 1), or basal lipolysis (Fig. 2C). However, lipolysis induced by noradrenaline (at the maximal effective concentration) or 8-bromo cyclic AMP was increased in mice lacking apoB100, reduced in apoB100-only mice, and intermediate in wild-type mice (Fig. 2C). Dose-response experiments showed similar hormone sensitivities in all three groups (not shown).
###end p 22
###begin title 23
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Effects of apoB100 in mice.
###end title 23
###begin p 24
###xml 621 622 617 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 778 779 774 775 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 218 224 <span type="species:ncbi:9986">rabbit</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
Plasma and gonadal fat pads were isolated after an overnight fast from 10-week-old wild-type mice (B100/B48) and mice lacking apoB100 (B48) or expressing only apoB100 (B100). (A) Western blots of plasma performed with rabbit anti-mouse apoB antibodies. (B) Gonadal fat pad cell volume (n>/=12 mice per group (B100/B48;B48; B100); p = 0.99; DF = 2,35; F-value = 0.015). (C) Basal (p = 0.13; DF = 2,39; F-value = 2.4), noradrenaline-stimulated (p = 0.019; DF = 2,36; F-value = 3.8), and 8-bromo cyclic AMP-stimulated lipolysis (p = 0.02; DF = 2,38; F-value = 3.8) (n>/=12 mice per group). (D) Resting oxygen consumption (VO2) and respiratory quotient (RQ) in mice kept at different environmental temperatures (n = 7-8 mice mice per group; DF = 1,13) p = 0.01; F-value = 3.3 for VO2 and p = 0.015; F-value = 3.1 for RQ). Error bars in (B-D) indicate SD. p-values were determined by ANOVA.
###end p 24
###begin title 25
###xml 35 39 <span type="species:ncbi:10090">Mice</span>
Basic Characteristics of the Study Mice.
###end title 25
###begin p 26
###xml 22 23 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 31 37 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Values are mean+/-SD. *p<0.05, daggerp<0.005 vs. apoB100/48 mice. Plasma were isolated after an overnight fast.
###end p 26
###begin p 27
###xml 126 133 126 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003771-t001">Table 1</xref>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 480 487 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2D</xref>
###xml 634 641 634 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2D</xref>
###xml 702 709 702 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003771.s001">Fig. S1</xref>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
Of note, mice lacking apoB100 and apoB100-only mice had lower plasma triglyceride and cholesterol levels than wild-type mice (Table 1), implying that plasma concentrations of cholesterol and triglycerides per se did not affect lipolysis in adipocytes. The increased lipolysis in mice lacking apoB100 did not lead to a leaner phenotype or to smaller fat cells, suggesting adaptive or parallel changes in whole-body energy metabolism. Indeed, oxygen consumption was increased (VO2, Fig. 2D) in these mice-but only at high temperatures, when lipid oxidation was concomitantly increased, as evidenced by a lower respiratory quotient (RQ, Fig. 2D). However, food intake was almost identical in both groups (Fig. S1, Supplementary online material). These results suggest that mice lacking apoB100 decrease their circulating lipids rather than body fat as a result of the increase in catecholamine-induced lipolysis by enhancing energy expenditure and fat oxidation.
###end p 27
###begin title 28
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Types of apoB and lipolysis in mouse adipocytes
###end title 28
###begin p 29
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 371 378 371 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g003">Fig. 3A</xref>
###xml 407 414 407 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g003">Fig. 3B</xref>
###xml 463 470 463 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g003">Fig. 3A</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 237 242 <span type="species:ncbi:10090">mouse</span>
Our mouse in vivo studies implied that apoB100-containing but not apoB48-containing lipoproteins affect noradrenaline-induced lipolysis in adipocytes. To explore this possibility further, we exposed 3T3-L1 adipocytes to equal amounts of mouse lipoproteins containing either apoB100 or apoB48. ApoB100 lipoproteins inhibited noradrenaline-induced but not basal lipolysis (Fig. 3A) in dose-dependent fashion (Fig. 3B). ApoB48 lipoproteins did not affect lipolysis (Fig. 3A). Thus, lipoproteins containing apoB100, but not those containing apoB48, are responsible for the interaction with adipocytes, leading to reduced lipolysis within these cells.
###end p 29
###begin title 30
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Effects of mouse apoB100 on 3T3-L1 cells and effects of Ldlr in the study mice.
###end title 30
###begin p 31
###xml 739 743 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 743 746 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 746 750 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 750 757 734 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 768 771 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 785 789 769 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 789 792 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 792 796 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 796 803 780 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 814 817 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1057 1058 1041 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 448 453 <span type="species:ncbi:10090">mouse</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 918 922 <span type="species:ncbi:10090">mice</span>
(A) Basal and noradrenaline-stimulated lipolysis in 3T3-L1 cells incubated with equal numbers of mouse lipoproteins containing only apoB100 (40 microg/ml medium, n = 10) or apoB48 (20 microg/ml medium, n = 4) or with vehicle alone (n = 7) for 48 hours; DF = 2,18 (p = 0.79; F-value = 0.24 for basal and p<0.001; F-value = 10.4 for noradrenaline-stimulated lipolysis). (B) Percent inhibition of lipolysis mediated by incubation of 3T3-L1 cells with mouse lipoproteins containing apoB100 at high (80 microg apoB/ml medium) and low (40 microg apoB/ml medium) concentrations or with vehicle alone (Control) (n = 9 for each concentration; p = 0.013; DF = 2,24; F-value = 5.6) for 48 hours. (C) Fat cell volume in gonadal fat pads isolated from Ldlr-/-Apob100/100 mice (Ldlr-/-, n = 13) and Ldlr+/+Apob100/100 mice (Ldlr+/+, n = 17) mice (p = 0.23). (D) Basal (p<0.05) and noradrenaline-stimulated (p<0.01) lipolysis in the mice described in (C). Error bars indicate SD. p-values were determined by ANOVA in (A-B) and unpaired t-test in (C-D), *p<0.05, **p<0.01 (t-test).
###end p 31
###begin title 32
The role of the LDL receptor on adipocytes
###end title 32
###begin p 33
###xml 57 60 57 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Kraemer1">[8]</xref>
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 213 217 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 217 224 217 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 254 257 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 250 261 250 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup>Apob</italic>
###xml 261 268 261 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 270 273 270 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Ishibashi1">[9]</xref>
###xml 428 435 428 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g003">Fig. 3C</xref>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g003">Fig. 3D</xref>
###xml 583 586 583 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 579 590 579 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup>Apob</italic>
###xml 590 597 590 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 604 611 604 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g003">Fig. 3D</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
Since the LDL receptor (LDLR) is expressed on adipocytes [8], we investigated its role in the interaction between apoB100 lipoproteins and adipocytes by analyzing apoB100-only mice that expressed the LDLR (Ldlr+/+Apob100/100) or were LDLR-deficient (Ldlr-/-Apob100/100) [9]. Apart from their plasma cholesterol levels, the two groups were phenotypically similar (values not shown). LDLR deficiency did not affect fat cell size (Fig. 3C) but decreased basal lipolysis slightly (Fig. 3D). Importantly, however, noradrenaline-induced glycerol release was almost threefold higher in Ldlr-/-Apob100/100 mice (Fig. 3D), suggesting that binding of apoB100-LDL to the LDLR is necessary to mediate the inhibition of lipolysis in adipocytes.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
ApoB100 is the main cholesterol transporter in the circulation and has a central role in atherogenesis. In this study, we show that plasma apoB100-containing lipoproteins interact directly with adipocytes, resulting in lower levels of catecholamine-induced lipolysis. VLDL and apoB48-containing lipoproteins had no effect on lipolysis, indicating that the interaction with adipocytes requires the LDLR. We also provide evidence that apoB100-LDL modulates lipid mobilization and energy expenditure. These findings reveal a novel role for apoB100-LDL as a signaling molecule between the liver and adipose tissues that may provide an important link between atherogenic dyslipidemias and the metabolic syndrome.
###end p 35
###begin p 36
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Frayn2">[10]</xref>
###xml 626 633 626 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g004">Fig. 4A</xref>
###xml 749 756 749 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1A</xref>
A role of apoB100-LDL as a liver-adipose signal is consistent with the notion that the liver is a major regulator of whole-body energy homeostasis and that white adipose tissue is an important energy reserve [10]. Indeed, fatty acids function as signaling molecules in the reverse direction, from the adipose tissue to the liver. During sympathetic activation, white adipose tissue releases fatty acids into the circulation at higher rates, at least in part through catecholamine-mediated activation of protein kinase A. This stimulates lipid oxidation and energy expenditure. The liver responds by increasing VLDL synthesis (Fig. 4A). The physiological significance of the observed correlation between plasma apoB100 levels and fat cell lipolysis (Fig. 1A) needs, however, to be interpreted with caution. For instance, this correlation could also be a consequence of one or several differential expressed genes with independent effects on both apoB100 plasma levels (either by affecting synthesis in the liver or clearance in the periphery) and lipolysis in fat cells.
###end p 36
###begin title 37
Model for cross-talk between the liver and adipose-tissue.
###end title 37
###begin p 38
###xml 171 179 <span type="species:ncbi:9606">patients</span>
In the normal state there is a balance between production of hepatic apoB100 containing lipoproteins and release of free fatty acid (FFA) from the adipose tissue. In FCHL patients, who have lower noradrenaline-induced lipolysis and increased levels of plasma lipoproteins containing aoB100, lowered lipid synthesis and decreased adipocyte fatty acid trapping lead to elevated levels of FFA in the circulation. Increased levels of circulating FFA activate apoB100 synthesis leading to elevated plasma apoB100 containing lipoprotein levels. In this fashion an imbalance between liver-adipose tissue is created and a "vicious circle" evolves. HSL indicates hormone sensitive lipase.
###end p 38
###begin p 39
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Sniderman1">[11]</xref>
###xml 432 435 432 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir1">[3]</xref>
###xml 437 440 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir2">[4]</xref>
###xml 629 633 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Cianflone1">[12]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Sniderman2">[13]</xref>
###xml 893 896 893 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir1">[3]</xref>
###xml 1039 1043 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Sniderman3">[14]</xref>
###xml 1045 1049 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Arner1">[15]</xref>
###xml 1051 1058 1051 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g004">Fig. 4B</xref>
###xml 641 649 <span type="species:ncbi:9606">Patients</span>
Our findings suggest that decreased LDL concentrations in the microcirculation of adipose tissue cause a reciprocal activation of lipolysis in white adipose tissue when apoB100-LDL levels are decreased. In FCHL and metabolic syndrome, which are characterized by very high levels of apoB100 [11], a liver-adipose tissue route could potentially be involved. We speculate that, when catecholamine-induced adipocyte lipolysis decreases [3], [4], adipocyte lipid synthesis is lowered to compensate for the reduced lipolysis. In support of this notion, lipid synthesis stimulation by acylation-stimulating protein is decreased in FCHL [12], [13]. Patients with FCHL have increased apoB100 levels and decreasing catecholamine-induced lipolysis but the fat cell size remains normal, suggesting a link between low lipolysis and low lipid synthesis in fat cells. Reduced turnover of lipids in fat cells [3] may lead to decreased adipocyte fatty acid trapping and elevated levels of circulating fatty acids, which in turn exacerbate the dyslipidemia [14], [15] (Fig. 4B).
###end p 39
###begin p 40
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Herz1">[16]</xref>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Nykjaer1">[17]</xref>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1F</xref>
###xml 738 745 738 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g001">Fig. 1G</xref>
###xml 1005 1009 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Amieux1">[18]</xref>
###xml 1010 1014 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Fricke1">[20]</xref>
###xml 1166 1170 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Amieux1">[18]</xref>
###xml 1172 1176 1154 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Planas1">[19]</xref>
###xml 1341 1342 1319 1320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1351 1358 1329 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2D</xref>
###xml 1598 1605 1576 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2B</xref>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
###xml 989 994 <span type="species:ncbi:10090">mouse</span>
There are numerous possibilities for how the interaction between apoB100-LDL and adipocyte LDLR may influence catecholamine signaling to the adipose tissue. The LDLR itself may mediate second signaling by mediating the uptake and degradation of LDL particles, which in turn may release molecules with signaling properties [16], [17]. We tested whether the cholesterol ester content of the apoB100-LDL particles may alter their inhibitory effects on catecholamine-induced lipolysis. However, reconstituting cholesterol esters of the apoB100-LDL particles with triglycerides had no effect (Fig. 1F). Despite this, we found that apoB100-LDL signaling through the LDLR altered gene expression of several genes whereof two in the PKA complex (Fig. 1G). The gene expression observations are consistent with the results of previous studies: first, the documented changes in Reg1alpha and Reg2beta in Reg1alpha-null mutant mice and the findings of lipolysis studies with selective PKA blockers in mouse fat cells [18]-[20] are in agreement with a decrease in catecholamine-induced lipolysis. Furthermore, knockout of Reg2beta results in a compensatory increase in Reg1alpha [18], [19]. The induction of apoB100-LDL of genes regulating fatty acid oxidation (CPT1, PPARalpha) are, in our view, in agreement with the measurements of metabolic rates (VO2 and RQ, Fig. 2D). A decrease in catecholamine-induced lipolysis seems to be coupled with an increase in fatty acid oxidation, thus the two phenomena appear to compensate each other which also is consistent with the absence of changes in fat cell volumes (Fig. 2B). However, the exact mechanism for how the LDLR/apoB100-LDL complex mediates changes to gene expression and inhibitory effect on lipolysis remains a topic for future studies.
###end p 40
###begin p 41
In conclusion, we have shown that apoB100-LDL mediates the inhibition of catecholamine-induced lipolysis in adipocytes through the LDLR. Our findings suggest a novel link between dyslipidemias and metabolic disorders such as FCHL and the metabolic syndrome. They also suggest that the beneficial actions of cholesterol-lowering agents such as statins may involve effects on the rate of lipolysis in adipocytes.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
Subjects
###end title 43
###begin p 44
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Kolaczynski1">[21]</xref>
###xml 73 76 <span type="species:ncbi:9606">men</span>
###xml 476 481 <span type="species:ncbi:9606">human</span>
###xml 785 796 <span type="species:ncbi:9606">participant</span>
The study subjects were 48 overweight but otherwise healthy Scandinavian men (body mass index, 25-53 kg/m2), aged 23-72 years, who were free from regular medication. In the morning after an overnight fast, a venous blood sample was obtained for analysis of serum apoB100 and apoA1 concentrations, and a subcutaneous fat biopsy (1-3 g) was obtained from the abdominal region by needle aspiration under local anesthesia as described [21]. For experiments in primary cultures of human pre-adipocytes, subcutaneous adipose tissue was obtained during cosmetic liposuction under general anesthesia from healthy subjects who were not selected on the basis of age, sex, or degree of obesity. The study was approved by the hospital's ethics committee. The study was explained in detail to each participant and written informed consent was obtained.
###end p 44
###begin title 45
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models
###end title 45
###begin p 46
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 11 20 11 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/&#8722;</sup></italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 125 134 125 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 213 216 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/&#8722;</sup></italic>
###xml 411 414 403 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Raabe1">[6]</xref>
###xml 444 448 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 465 469 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 469 480 461 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 609 616 593 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2A</xref>
###xml 646 650 630 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 650 659 634 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 813 817 797 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 817 824 801 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 830 833 814 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Farese1">[7]</xref>
###xml 862 869 846 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003771-g002">Fig. 2A</xref>
###xml 872 876 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 876 879 860 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 879 883 863 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 883 890 867 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 895 899 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 899 902 883 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 902 906 886 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 906 913 890 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 946 950 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 950 953 934 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 959 962 943 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Ishibashi1">[9]</xref>
###xml 968 972 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 972 979 956 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
###xml 996 1000 <span type="species:ncbi:10090">mice</span>
###xml 1287 1291 <span type="species:ncbi:10090">Mice</span>
In the Mttpflox/floxMx1-Cre+/- mice used for the study, the gene for microsomal triglyceride transfer protein is floxed (Mttpflox/flox) and can be recombined in the liver upon induction of Cre-recombinase (Mx1-Cre+/-) with polyinosinic-polycytidylic ribonucleic acid (1 microg/microl; Sigma). This recombination results in the termination of hepatic VLDL synthesis and depletion of plasma apoB100, as described [6]. Two weeks before sacrifice, Mttp was recombined (MttpDelta/Delta), which interrupts hepatic synthesis of apoB100-containing lipoproteins, leaving only apoB48-containing lipoproteins in plasma (Fig. 2A). Littermate wild-type mice (Mttpflox/flox), injected with phosphate-buffered saline, had approximately equal concentrations of plasma apoB100 and apoB48, as shown by western blot analysis, while Apob100/100 mice [7] only had apoB100 in plasma (Fig. 2A). Ldlr-/-Apob100/100 and Ldlr+/+Apob100/100 mice were generated by crossing Ldlr-/- mice [9] with Apob100/100 mice. The study mice had been backcrossed at least six times (>95% C57BL/6, <5% 129/SvJae), were housed in a pathogen-free barrier facility (12 h light/12 h dark cycle), and were fed rodent chow containing 4% fat. Genotypes were determined by polymerase chain reaction using genomic DNA from tail biopsies. Mice were sacrificed at 10 weeks of age. Gonadal and renal fat pads were immediately removed and put into tubes containing 37degreesC phosphate-buffered saline for following analyses.
###end p 46
###begin title 47
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse characteristics and metabolic rate
###end title 47
###begin p 48
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 114 120 <span type="species:ncbi:9986">rabbit</span>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 227 238 <span type="species:ncbi:3704">horseradish</span>
###xml 258 264 <span type="species:ncbi:9793">donkey</span>
###xml 270 276 <span type="species:ncbi:9986">rabbit</span>
Mouse plasma samples (2 microl) were fractionated by SDS-PAGE using 4% gels. The apoB proteins were detected with rabbit antiserum against mouse apoB (Biosite, Taby, Sweden). The binding of primary antibodies was assessed with horseradish peroxidase-labeled donkey anti-rabbit antibodies and ECL western blotting reagents (Amersham Biosciences, GE Healthcare Biosciences, Little Chalfont, Buckinghamshire, England). Plasma cholesterol and triglyceride concentrations were determined with colorimetric assays (Infinity cholesterol/triglyceride kits; Thermo Electron, Melbourne, Australia). Plasma glucose levels were measured with Precision Xtra (MediScience, Cherry Hill, NJ).
###end p 48
###begin p 49
###xml 32 43 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 28 43 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp<sup>&#916;/&#916;</sup></italic>
###xml 66 70 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 70 79 62 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 238 242 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Hogberg1">[22]</xref>
###xml 592 596 566 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0.75</sup>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Eight mice lacking apoB100 (MttpDelta/Delta) and seven wild-type (Mttpflox/flox) mice were investigated in metabolic cages, and food intake was recorded. Energy expenditure and respiratory quotient were determined at week 10 as described [22]. In brief, after an acclimatization period, oxygen consumption and carbon dioxide production were measured at 15-32.5degreesC. Experiments conducted at temperatures of 15-27.5degreesC lasted for up to 5 hours; those conducted at temperatures above 27.5degreesC lasted for 2.5 hours (to avoid stress caused by the heat). Oxygen consumption (ml/min/kg0.75) and the respiratory quotient were calculated with a calorimetry calculation program (written in DasyLab; Somedic, Horby, Sweden).
###end p 49
###begin title 50
RNA Isolation and Real-Time PCR
###end title 50
###begin p 51
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subcutaneous fat that had been stored in Trizol reagent at -80degreesC were homogenized (FastPrep, Qbiogene; Irvine, CA) in fresh Trizol. Total RNA was prepared with RNeasy mini kits (Qiagen, Valencia, CA) using a DNAse I treatment step according to the manufacturer's protocol. RNA quality was assessed with a Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA). Total RNA (0.3-0.5 microg) was reverse transcribed with Superscript II as recommended by the manufacturer (Invitrogen). After dilution to 65 microl, cDNA (3 microl) was amplified by real-time PCR with 1x TaqMan universal PCR master mix (Applied Biosystems, Foster City, CA). Assay-on-Demand kits containing corresponding primers and probes were from Applied Biosystems. The mRNA levels were normalized to acidic ribosomal phosphoprotein P0 (RPLP0).
###end p 51
###begin title 52
Lipoprotein isolation
###end title 52
###begin p 53
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Boquist1">[23]</xref>
###xml 533 544 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 529 544 523 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp<sup>&#916;/&#916;</sup></italic>
###xml 556 560 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 560 567 546 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 441 446 <span type="species:ncbi:10090">Mouse</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
Human VLDL and LDL in 60 ml of blood from a normolipidemic donor were isolated by density-gradient ultracentrifugation, as described [23]. In brief, after a 16-hour spin in a Beckman SW40 rotor at 40,000 rpm at 15degreesC, the top 0.5 ml layer was aspirated (VLDL). The tubes were then sliced 42 mm from the top to harvest the LDL fraction. The LDL and VLDL fractions were each passed through a PD-10 desalting column (Amersham Bioscience). Mouse lipoproteins containing apoB48 or apoB100 were isolated from plasma pooled from 8 MttpDelta/Delta mice and 8 Apob100/100 mice, respectively. The pooled plasma was mixed with 1.42 g/ml NaBr to a final density of 1.10 g/ml and ultracentrifuged at 40,000 rpm in a Beckman SW40 rotor for >80 hours at 10degreesC. The top 0.5 ml of the tube containing LDL and less dense lipoproteins was collected. ApoB concentrations in the lipoprotein fractions were assessed from total protein concentrations. The LDL fractions used in the current experiments contained 5.4+/-1.9 mmol/L cholesterol, 0.58+/-0.12 mmol/l triglycerides and 483+/-62 mg/l apoB100. We have run aliquots of these fractions on SDS-acrylamide gels showing a robust apoB100 band and no other degradation products or other proteins (data not shown).
###end p 53
###begin title 54
Preparation of reconstituted low density lipoprotein
###end title 54
###begin p 55
###xml 47 51 47 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Krieger1">[24]</xref>
###xml 197 203 <span type="species:ncbi:4113">potato</span>
Reconstituted LDL was prepared as described by [24]. In brief, LDL was dialyzed at 4degreesC against 0.3 mM EDTA, pH 7.0. Aliquots of 1.9 mg LDL were transferred to glass tubes containing 25 mg of potato starch and frozen in liquid nitrogen. The samples were lyophilized and the endogenous lipids were extracted from the lyophilized LDL with heptane. After removing the last heptane supernatant, 200 microl heptane containing 6 mg of glyceryl trilinoleate or cholesteryl linoleate (Sigma-Aldrich) were added. The mixture was incubated for 1 hour at 4degreesC followed by evaporation of the heptane under a gentle stream of nitrogen until the samples were completely dry. One ml of PBS, pH 7.4, was then added to dissolve the reconstituted LDL and left overnight at 4degreesC. The solubilized reconstituted LDL was separated from the bulk of the starch and from excess lipids by centrifugation at 2000 rpm for 10 min, 4degreesC. The supernatant was further centrifuged at 9100 g for 10 min, 4degreesC and finally filtered through a 0.22 microm Millipore filter.
###end p 55
###begin title 56
Adipose tissue and cell cultures
###end title 56
###begin p 57
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 214 220 <span type="species:ncbi:9913">bovine</span>
Human subcutaneous adipose tissue and mouse fat pads were cut into fragments, incubated with collagenase (0.5 g/ml; Sigma, St. Louis, MO) in Krebs Ringer phosphate buffer (pH 7.4) supplemented with 40 g/l dialyzed bovine serum albumin (fraction V; Sigma) for 1 hour at 37degreesC, and filtered through a nylon mesh. The supernatant, containing mature adipocytes, was used as described below.
###end p 57
###begin p 58
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Ryden1">[25]</xref>
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 208 209 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 212 213 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 559 560 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 599 600 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 929 930 917 918 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1222 1226 1208 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Ryden1">[25]</xref>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 465 469 <span type="species:ncbi:9913">calf</span>
Pre-adipocytes were isolated and differentiated as described [25]. The cell pellet obtained from human subcutaneous adipose tissue was resuspended in 10 ml of erythrocyte lysis buffer (0.154 M NH4Cl, 5.7 mM K2HPO4, and 0.1 mM EDTA, pH 7.3) and centrifuged. The pellet was resuspended in 10 ml of DMEM/F12 medium (Invitrogen) and filtered through a nylon filter. After an additional centrifugation, the cells were resuspended in DMEM/F12 supplemented with 10% fetal calf serum and penicillin/streptomycin (100 mg/l), seeded into 12-well plates (50,000 cells/cm2), and kept at 37degreesC in 5.3 kPa CO2 for 18-20 hours. Cells were then washed with DMEM/F12 and cultured in chemically defined serum-free medium. Rosiglitazone (kindly provided by SmithKline Beecham Pharmaceuticals) was added to a final concentration of 10 mmol/l (days 1-6) to induce differentiation. Cells were maintained in the medium at 37degreesC and 5.3 kPa CO2 for a total of 10 days and incubated with fresh lipoproteins for 8, 24, or 48 hours. Only cultures with a differentiation density >/=70% and <5% contaminating endothelial cells were used. Differentiation was determined by quantifying glycerol-3-phosphate dehydrogenase activity as described [25].
###end p 58
###begin p 59
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Dicker1">[26]</xref>
###xml 488 490 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 532 534 526 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 424 430 <span type="species:ncbi:9913">bovine</span>
Standard procedures were used to grow and differentiate 3T3-L1 cells. Lipolysis experiments with differentiated 3T3-L1 cells or human pre-adipocytes were conducted as described [26]. In brief, pre-adipocytes were incubated in medium with or without fresh mouse or human lipoproteins for 48 hours. The medium was removed, and the cells were washed and incubated for 3 hours at 37degreesC in DMEM/F12 medium supplemented with bovine serum albumin (20 g/l) with and without noradrenaline (10-4 mol/l). In methodological experiments, 10-4 mol/l of noradrenaline always produced the maximal lipolytic effect. Aliquots were collected and kept at -20degreesC for measurement of glycerol concentration (an index of lipolysis). To control for interexperimental differences in adipocyte differentiation, glycerol release was normalized to the glycerol-3-phosphate dehydrogenase activity and protein content of each sample.
###end p 59
###begin p 60
###xml 87 90 87 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir1">[3]</xref>
###xml 92 95 92 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Reynisdottir2">[4]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Spalding1">[27]</xref>
###xml 739 743 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Hellmer1">[28]</xref>
###xml 769 771 763 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 777 779 771 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 792 794 786 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 854 856 848 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 883 885 877 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1059 1061 1053 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1123 1125 1117 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 138 143 <span type="species:ncbi:9606">human</span>
###xml 148 153 <span type="species:ncbi:10090">mouse</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 1003 1008 <span type="species:ncbi:9606">human</span>
Mature collagenase-isolated fat cells were used for lipolysis experiments as described [3], [4]. The same lipolysis protocol was used for human and mouse adipocyte preparations. Lipolysis was measured in one of the two gonadal fat pads from each mouse. In preliminary experiments, similar results were obtained with gonadal fat pads and equal amounts of renal adipose tissue. Fat-cell size and number were measured (see below) [27]. In lipolysis experiments, diluted cell suspensions (2%, vol/vol) were incubated in albumin-containing buffer, pH 7.4, containing glucose (1 g/l) and ascorbic acid (0.1 g/l) for 2 hours at 37degreesC with air as the gas phase. Glycerol release into the medium was determined by bioluminescence as described [28] and expressed as mol ⋅ 10-6 ⋅ 2 h-1 ⋅ cells ⋅ 10-7. Adipocytes were incubated in the absence or presence of 10-6 mol/l noradrenaline and 10-3 mol/l 8-bromo cyclic AMP (a phosphodiesterase-insensitive cyclic AMP analogue). In the clinical experiments isolated human fat cells were also incubated with isoprenaline 10-6 mol/l (nonselective beta adrenergic agonist) and forskolin 10-4 mol/l (activator of adenylyl cyclase). These concentrations of lipolytic agents always yielded maximal stimulation in mature adipocytes in control experiments. When several hormone concentrations were used, the concentration-response curves were analyzed for half-maximum effective concentration.
###end p 60
###begin title 61
Measurement of fat cell size and volume
###end title 61
###begin p 62
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Hirsch1">[29]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Bjorntorp1">[30]</xref>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003771-Bjorntorp2">[31]</xref>
###xml 194 199 <span type="species:ncbi:10090">mouse</span>
###xml 452 457 <span type="species:ncbi:9606">human</span>
###xml 692 695 <span type="species:ncbi:9606">man</span>
Mean fat cell size and volume were determined on isolated fat cells as follows: Fat cell diameter was measured in direct microscopy and averaging the diameter of 100 cells in each individual or mouse. The mean fat cell volume and size were calculated by formulas developed by Hirsch and Gallian [29]. Coefficient of variation for the method is 2-3%. The mean values are essentially the same as those determined from fat cell sizing of intact pieces of human adipose tissue [30]. Total number of fat cells in the body was calculated as the amount of body fat divided by the mean fat cell weight. It is well known that mean fat cell volume and weight differs between various adipose regions in man. However, the differences are small and only introduce a marginal error when just one depot is used for the calculation of total fat cell number as discussed [31].
###end p 62
###begin title 63
Statistical analyses
###end title 63
###begin p 64
###xml 35 36 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Values were compared with unpaired t tests, simple and multiple regression analyses, or analysis of variance (ANOVA) followed by Fisher's post-hoc test. Data with a skewed distribution were log normalized before statistical analyses.
###end p 64
###begin title 65
Supporting Information
###end title 65
###begin p 66
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Food intake in B100/48 (n = 7) and B48 (n = 8) mice. Error bars indicate SD.
###end p 66
###begin p 67
(18.20 MB TIF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
We thank Kerstin Wahlen, Eva Sjolin, and Karin Danell-Toverud for technical assistance.
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
###end article-title 71
###begin article-title 72
Fatty acid metabolism in adipose tissue, muscle and liver in health and disease.
###end article-title 72
###begin article-title 73
Multiple lipolysis defects in the insulin resistance (metabolic) syndrome.
###end article-title 73
###begin article-title 74
Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
###end article-title 74
###begin article-title 75
A new lipase in regulating lipid mobilization: hormone-sensitive lipase is not alone.
###end article-title 75
###begin article-title 76
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.
###end article-title 76
###begin article-title 77
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
###end article-title 77
###begin article-title 78
###xml 37 40 <span type="species:ncbi:10116">rat</span>
Low-density lipoprotein receptors in rat adipocytes: regulation with fasting.
###end article-title 78
###begin article-title 79
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
###end article-title 79
###begin article-title 80
Regulation of fatty acid delivery in vivo.
###end article-title 80
###begin article-title 81
Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm.
###end article-title 81
###begin article-title 82
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.
###end article-title 82
###begin article-title 83
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 12 15 <span type="species:ncbi:9606">men</span>
###xml 21 26 <span type="species:ncbi:9606">women</span>
Of mice and men (and women) and the acylation-stimulating protein pathway.
###end article-title 83
###begin article-title 84
The adipocyte, fatty acid trapping, and atherogenesis.
###end article-title 84
###begin article-title 85
Is familial combined hyperlipidaemia a genetic disorder of adipose tissue?
###end article-title 85
###begin article-title 86
Cellular signalling by lipoprotein receptors.
###end article-title 86
###begin article-title 87
The low-density lipoprotein receptor gene family: a cellular Swiss army knife?
###end article-title 87
###begin article-title 88
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice.
###end article-title 88
###begin article-title 89
Mutation of the RIIbeta subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue.
###end article-title 89
###begin article-title 90
Cooperative activation of lipolysis by protein kinase A and protein kinase C pathways in 3T3-L1 adipocytes.
###end article-title 90
###begin article-title 91
###xml 30 35 <span type="species:ncbi:9606">human</span>
A new technique for biopsy of human abdominal fat under local anaesthesia with Lidocaine.
###end article-title 91
###begin article-title 92
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Temperature dependence of O2 consumption; opposite effects of leptin and etomoxir on respiratory quotient in mice.
###end article-title 92
###begin article-title 93
###xml 131 134 <span type="species:ncbi:9606">men</span>
Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.
###end article-title 93
###begin article-title 94
Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein particle.
###end article-title 94
###begin article-title 95
###xml 88 93 <span type="species:ncbi:9606">human</span>
Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells.
###end article-title 95
###begin article-title 96
###xml 39 44 <span type="species:ncbi:9606">human</span>
Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots.
###end article-title 96
###begin article-title 97
###xml 33 39 <span type="species:ncbi:9606">humans</span>
Dynamics of fat cell turnover in humans.
###end article-title 97
###begin article-title 98
Automatic luminometric kinetic assay of glycerol for lipolysis studies.
###end article-title 98
###begin article-title 99
###xml 54 57 <span type="species:ncbi:9606">man</span>
Methods for the determination of adipose cell size in man and animals.
###end article-title 99
###begin article-title 100
###xml 53 58 <span type="species:ncbi:9606">human</span>
Size, number and function of adipose tissue cells in human obesity.
###end article-title 100
###begin article-title 101
###xml 78 81 <span type="species:ncbi:9606">man</span>
Effects of age, sex, and clinical conditions on adipose tissue cellularity in man.
###end article-title 101
###begin p 102
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 102
###begin p 103
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by grants from the Swedish Research Council (P.Ar. and J.B.), the Swedish Diabetes Association (P.Ar.), the Swedish Heart-Lung Foundation (P.Ar., J.B., and A.H.), the Novo Nordic Foundation (P.Ar.) and the King Gustaf V and Queen Victoria Foundation (P.Ar., J.B.) and the European Commission, 6th Framework Program (contract LSHM-CT-2005-01873). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.
###end p 103

